Dr Harold David Simmons, MD in Grenada, MS - Pediatrics

Dr Harold David Simmons, MD is a Pediatrics physician based in Grenada, Mississippi. Dr Harold David Simmons is licensed to practice in Mississippi (license number 11777) and his current practice location is 340 Van Dorn St, Grenada, Mississippi. He can be reached at his office (for appointments etc.) via phone at (662) 226-0325.

NPI number for Dr Harold David Simmons is 1497742704 and his current mailing address is 340 Van Dorn St, Grenada, Mississippi. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1497742704.

Contact Information

	Dr Harold David Simmons, MD
	340 Van Dorn St, Grenada, MS 38901-4738
	(662) 226-0325
	(662) 226-0327

Physician's Profile

Full Name	Dr Harold David Simmons
Gender	Male
Speciality	Pediatrics
Location	340 Van Dorn St, Grenada, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1497742704
Provider Enumeration Date: 10/03/2005
Last Update Date: 10/04/2013

Medical Identifiers

Medical identifiers for Dr Harold David Simmons such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1497742704	NPI	-	NPPES
00016473	Medicaid	MS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	11777 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Harold David Simmons is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Harold David Simmons, MD 340 Van Dorn St, Grenada, MS 38901-4738 Ph: (662) 226-0325	Dr Harold David Simmons, MD 340 Van Dorn St, Grenada, MS 38901-4738 Ph: (662) 226-0325

News Archive

TUHS, GE Healthcare collaborate to provide high-quality radiologic imaging services

Academic medical centers across the U.S. are experiencing increasing pressure to enhance value - deliver higher quality at lower cost - as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics. Initiatives to promote value typically involve reimbursement arrangements between health insurers and providers that align financial, efficiency and quality incentives.

FOI Request by Bowel Cancer UK highlights big variation in tests for lynch syndrome

Bowel Cancer UK submitted the FOI request in November 2014 to every NHS trust in England, health board in Scotland and health and social care trust in Northern Ireland to establish the number of trusts/health boards which were implementing the testing for all bowel cancer patients under 50, as mandated by the Royal College of Pathologists. Lynch syndrome is responsible for around one in 12 cases of bowel cancer in people aged under 50.

Alnylam announces clinical data from patisiran Phase 2 OLE study for treatment of patients with FAP

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today initial 12-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) in patients with familial amyloidotic polyneuropathy (FAP).

Advanced Life Sciences second-quarter net loss decreases to $2.1 million

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the second quarter ended June 30, 2010.

Five key proteins form new, early-warning blood test before heart attack strikes

A team of Johns Hopkins biochemists has identified a mixed bag of five key proteins out of thousands secreted into blood draining from the heart's blood vessels that may together or in certain quantities form the basis of a far more accurate early warning test than currently in use of impending heart attack in people with severely reduced blood flow, or ischemia.

Pediatrics Doctors in Grenada, MS

Valiparambil Balakrishnan Praveen Kumar, M.D.
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 960 Avent Dr, Grenada, MS 38901
Phone: 662-227-7008

Dr Harold David Simmons, MD - Pediatrics in Grenada, MS